Dengfeng Ge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dengfeng Ge has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Jianming Zhang
Jiangsu University
2 shared publications - Qian Yu
School of Life Sciences, Jiangsu University, Zhenjiang 212013, China
2 shared publications Hong Liu
School of Chemistry and Chemical Engineering, Jiangsu University, 301 Xuefu Rd, Zhenjiang 212013, China
1 shared publicationJiaojiao Zhang
School of Chemistry and Chemical Engineering, Jiangsu University, 301 Xuefu Rd, Zhenjiang 212013, China
1 shared publication- Jiaojiao Zhang
School of Chemistry and Chemical Engineering, Jiangsu University, Zhenjiang 212013, China
1 shared publication - Long Zhang
Jiangsu University
1 shared publication
Latest Publications
- Open Access
- 3 May 2024
- Published by MDPI AG in Nanomaterials
- Vol. 14 (9) , 797
Metal–Organic Framework Nanomaterials as a Medicine for Catalytic Tumor Therapy: Recent Advances
Nanomaterials, with unique physical, chemical, and biocompatible properties, have attracted significant attention as an emerging active platform in cancer diagnosis and treatment. Amongst them, metal–organic framework (MOF) nanostructures are particularly promising as a nanomedicine due to their exceptional surface functionalities, adsorption properties, and organo-inorganic hybrid characteristics. Furthermore, when bioactive substances are integrated into the structure of MOFs, these materials can be used as anti-tumor agents with superior performance compared to traditional nanomaterials. In this review, we highlight the most recent advances in MOFs-based materials for tumor therapy, including their application in cancer treatment and the underlying mechanisms.
- 3 May 2024
- Published by MDPI AG in Nanomaterials
- Vol. 14 (9) , 797
Open AccessMetal–Organic Framework Nanomaterials as a Medicine for Catalytic Tumor Therapy: Recent Advances
Nanomaterials, with unique physical, chemical, and biocompatible properties, have attracted significant attention as an emerging active platform in cancer diagnosis and treatment. Amongst them, metal–organic framework (MOF) nanostructures are particularly promising as a nanomedicine due to their exceptional surface functionalities, adsorption properties, and organo-inorganic hybrid characteristics. Furthermore, when bioactive substances are integrated into the structure of MOFs, these materials can be used as anti-tumor agents with superior performance compared to traditional nanomaterials. In this review, we highlight the most recent advances in MOFs-based materials for tumor therapy, including their application in cancer treatment and the underlying mechanisms.
- 27 March 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (33) , 4463-4466
Magnetostrictive-piezocatalytic CoFe 2 O 4 @UiO-66 nanohybrid and its potential for deep-seated tumor treatment
Driven by an AC-magnetic field, the CoFe 2 O 4 @UiO-66 nanohybrids with magnetostrictive-piezoelectric property showcase bright potential to efficiently kill cancer cells buried in thick tissues.
- 27 March 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (33) , 4463-4466
Magnetostrictive-piezocatalytic CoFe 2 O 4 @UiO-66 nanohybrid and its potential for deep-seated tumor treatment
Driven by an AC-magnetic field, the CoFe 2 O 4 @UiO-66 nanohybrids with magnetostrictive-piezoelectric property showcase bright potential to efficiently kill cancer cells buried in thick tissues.